Screener
Mirum Pharmaceuticals, Inc. MIRM Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Accrued sales deductions and other | $62,501 | $51,375 |
| Accrued compensation and related benefits | 28,389 | 47,276 |
| Accrued clinical trials | 22,872 | 13,959 |
| Accrued professional service fees | 21,886 | 17,292 |
| Accrued contract manufacturing and non-clinical costs | 17,670 | 8,721 |
| Accrued royalties payable | 16,204 | 16,208 |
| Operating lease liabilities, current | 2,405 | 2,139 |
| Accrued loss on firm purchase commitments | 2,107 | 2,107 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s accrued manufacturing costs?
- Mirum Pharmaceuticals, Inc. (MIRM) reported accrued manufacturing costs of $28.39M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s accrued manufacturing costs changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s accrued manufacturing costs increased by 5.8% year-over-year, from $26.84M to $28.39M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s accrued manufacturing costs?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s accrued manufacturing costs has grown at a 50.3% compound annual growth rate (CAGR), from $20.94M to $47.28M.
- What does accrued manufacturing costs mean?
- Accrued liabilities related to manufacturing and production activities.
Ask your AI about Mirum Pharmaceuticals, Inc.'s accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude